Circulating tumor DNA (ctDNA) dynamics and survival outcomes in patients with advanced NSCLC and high (≥50%) PD-L1 expression Published Date September 15, 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen
